We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
-7.87%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$12B
AUM Growth
-$1.05B
Cap. Flow
+$29.7M
Cap. Flow %
0.25%
Top 10 Hldgs %
34.83%
Holding
1,447
New
32
Increased
612
Reduced
360
Closed
43

Sector Composition

Rank Sector Weight
1 Real Estate 59.18%
2 Technology 9.44%
3 Healthcare 4.32%
4 Consumer Discretionary 4.16%
5 Financials 4.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RYTM icon
1151
Rhythm Pharmaceuticals
RYTM
$7.41B
$4K ﹤0.01%
172
SNDX icon
1152
Syndax Pharmaceuticals
SNDX
$1.76B
$4K ﹤0.01%
167
VCYT icon
1153
Veracyte
VCYT
$4.53B
$4K ﹤0.01%
266
DCPH
1154
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$4K ﹤0.01%
199
BLU
1155
DELISTED
BELLUS Health Inc.
BLU
$4K ﹤0.01%
398
ALEC icon
1156
Alector
ALEC
$172M
$3K ﹤0.01%
277
ANAB icon
1157
AnaptysBio
ANAB
$1.57B
$3K ﹤0.01%
105
ARQT icon
1158
Arcutis Biotherapeutics
ARQT
$3.56B
$3K ﹤0.01%
172
CHRS icon
1159
Coherus Oncology
CHRS
$222M
$3K ﹤0.01%
262
DSGN icon
1160
Design Therapeutics
DSGN
$765M
$3K ﹤0.01%
162
ERAS icon
1161
Erasca
ERAS
$6.37B
$3K ﹤0.01%
354
FSLY icon
1162
CALL
Fastly Inc
FSLY
$3.31B
$3K ﹤0.01%
100
GERN icon
1163
Geron
GERN
$917M
$3K ﹤0.01%
1,407
GOSS icon
1164
Gossamer Bio
GOSS
$100M
$3K ﹤0.01%
260
INVA icon
1165
Innoviva
INVA
$1.58B
$3K ﹤0.01%
260
KROS icon
1166
Keros Therapeutics
KROS
$200M
$3K ﹤0.01%
80
KURA icon
1167
Kura Oncology
KURA
$816M
$3K ﹤0.01%
227
KYMR icon
1168
Kymera Therapeutics
KYMR
$8.84B
$3K ﹤0.01%
150
MNKD icon
1169
MannKind Corp
MNKD
$1.21B
$3K ﹤0.01%
855
MRUS
1170
DELISTED
Merus
MRUS
$3K ﹤0.01%
125
PLRX icon
1171
Pliant Therapeutics
PLRX
$66.3M
$3K ﹤0.01%
123
QURE icon
1172
uniQure
QURE
$2.79B
$3K ﹤0.01%
158
RCKT icon
1173
Rocket Pharmaceuticals
RCKT
$344M
$3K ﹤0.01%
218
REPL icon
1174
Replimune Group
REPL
$452M
$3K ﹤0.01%
160
RLMD icon
1175
Relmada Therapeutics
RLMD
$555M
$3K ﹤0.01%
83

Similar funds

Daiwa Securities Group's Q3 2022 Portfolio in Review

As of Q3 2022, Daiwa Securities Group held 1,447 positions worth $12B, down 8% from $13.1B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Daiwa Securities Group's Q3 2022 filing shows 32 new, 612 increased, 360 reduced and 43 closed positions. Its largest new stake was NextEra Energy, Inc. 5.279% Corporate Units: 150,000 shares worth $7.43M. The largest sale was Duke Realty Corp., an estimated $243M.

By sector, the portfolio is most concentrated in Real Estate at 59% of assets, down from 61% a quarter earlier, followed by Technology and Healthcare.

  • Daiwa Securities Group's largest Q3 2022 buy was NextEra Energy, Inc. 5.279% Corporate Units: 150,000 shares worth $7.43M.
  • Daiwa Securities Group added most to First Industrial Realty Trust in Q3 2022, an estimated $172M increase.
  • Daiwa Securities Group's biggest Q3 2022 reduction was Duke Realty Corp., cutting an estimated $243M.
  • Daiwa Securities Group fully exited Chefs' Warehouse in Q3 2022, selling an estimated $2.69M.
  • Daiwa Securities Group's ten largest holdings make up 35% of its $12B portfolio in Q3 2022.
  • Daiwa Securities Group opened 32 new positions and closed 43 in Q3 2022.
  • Daiwa Securities Group's portfolio value fell 8% quarter-over-quarter to $12B.

Based on Daiwa Securities Group's 13F filing for Q3 2022, filed 2 Nov 2022.